Vicki L. Sato - May 30, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Stock symbol
VIR
Transactions as of
May 30, 2024
Transactions value $
$0
Form type
4
Date filed
6/3/2024, 12:16 PM
Previous filing
May 17, 2024
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +8K +0.61% $0.00 1.32M May 30, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +16K $0.00 16K May 30, 2024 Common Stock 16K $10.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.